Editor’s Choice: New Discoveries and Positive Results

Happy Friday!

The world could always use more good news, and this week we’ve got some new discoveries to discuss. Up first, details on a trial that may have finally found a drug that can reduce the risk of death in severe COVID-19 cases. We also have information about positive results from a phase 1 trial for a therapy targeting the root cause of chronic urticarias, a disease that significantly impacts a patient’s quality of life. Finally, knowledge is always the best defense, and we’ve got a summary of a study that describes a new rare genetic disorder called TRAF7 syndrome. We hope you have a great weekend!

 

This Trial May Have Finally Found a Drug That can Reduce the Risk of Death in Severe COVID-19

The finding may herald a major breakthrough in the treatment of the disease; treatment with just a small dose of the medication was able to reduce the risk of death significantly.

 

Positive Results Announced for a Phase 1 Trial Targeting Root of Chronic Urticarias

This disease can result in decreased energy, insomnia, social withdrawal, and even depression.

 

Study Describes New Rare Disease: TRAF7 Syndrome

Some of the characteristics include distinctive facial features as well as skeletal abnormalities affecting the chest, fingers, and neck.

 


Do you have a rare disease experience of your own? Share with us here.

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email